CJ Bioscience (XKRX:311690) Accounts Payable & Accrued Expense : ₩1,542 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is CJ Bioscience Accounts Payable & Accrued Expense?

CJ Bioscience's quarterly accounts payable & accrued expense increased from Sep. 2024 (₩2,354 Mil) to Dec. 2024 (₩4,433 Mil) but then declined from Dec. 2024 (₩4,433 Mil) to Mar. 2025 (₩1,542 Mil).

CJ Bioscience's annual accounts payable & accrued expense declined from Dec. 2022 (₩3,933 Mil) to Dec. 2023 (₩2,943 Mil) but then increased from Dec. 2023 (₩2,943 Mil) to Dec. 2024 (₩4,433 Mil).

CJ Bioscience Accounts Payable & Accrued Expense Historical Data

The historical data trend for CJ Bioscience's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CJ Bioscience Accounts Payable & Accrued Expense Chart

CJ Bioscience Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,112.03

2,287.23

3,933.15

2,943.48

4,433.07

CJ Bioscience Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2,115.07	2,852.43	2,353.85	4,433.07	1,542.37

CJ Bioscience Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

CJ Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CJ Bioscience Inc (XKRX:311690) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

7th floor, Grand Central Building B, 14 Sejong-Daero, Jung-gu, Seoul, KOR

Website

https://www.cjbioscience.com

CJ Bioscience Inc is engaged in directing a healthy life based on microbiological research. It presents directions and solutions to all fields of research on the microbiome, such as academia in the bioinformatics field, R&D centers of hospitals and research institutes, and NGS (next-generation sequencing) service companies. Its services includes NGS, EZBioCloud, Healthcare among others.

CJ Bioscience Headlines

No Headlines